Global Balloon-Expandable Stents Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Balloon-Expandable Stents Market Analysis

The balloon-expandable stents market is experiencing significant growth driven by advancements in cardiovascular treatments and the rising prevalence of coronary artery disease. Balloon-expandable stents are widely used in angioplasty procedures due to their precision in placement and ability to restore blood flow efficiently. These stents, primarily made of metallic materials such as stainless steel and cobalt-chromium, provide structural support to narrowed arteries, ensuring improved patient outcomes. The market is expanding due to an increasing geriatric population, a higher incidence of lifestyle-related diseases, and continuous technological advancements in stent design. Recent developments include drug-eluting balloon-expandable stents that reduce restenosis risk and improve safety profiles. Leading companies such as Medtronic, Boston Scientific, and Abbott are driving innovation and launching advanced products to address evolving clinical needs. With a growing demand for minimally invasive procedures and enhanced treatment outcomes, the balloon-expandable stents market is expected to witness steady growth in the coming years.

Balloon-Expandable Stents Market Size

The global balloon-expandable stents market size was valued at USD 3.10 billion in 2024 and is projected to reach USD 5.75 billion by 2032, with a CAGR of 8.04% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Balloon-Expandable Stents Market Trends

“Advancements in Interventional Cardiology”

The balloon-expandable stents market is witnessing steady growth due to the rising prevalence of cardiovascular diseases and advancements in interventional cardiology. Balloon-expandable stents are preferred for their precision, high radial strength, and ability to restore blood flow effectively during angioplasty procedures. Innovations such as drug-eluting stents (DES) are a key market driver, as they release medications to prevent restenosis, enhancing long-term outcomes. A notable trend is the increasing adoption of bioresorbable balloon-expandable stents, which dissolve over time, reducing long-term complications associated with permanent implants. The market is further driven by a growing geriatric population, lifestyle-related risk factors, and the demand for minimally invasive treatments. These factors collectively support the expansion of the balloon-expandable stents market, making it a vital segment in cardiovascular care.

Report Scope and Balloon-Expandable Stents Market Segmentation 

Balloon-Expandable Stents Market Definition

Balloon-expandable stents are specialized medical devices used in cardiovascular procedures, primarily angioplasty, to open and support narrowed or blocked blood vessels. These stents are mounted on a deflated balloon catheter, which is guided to the target site within the artery. Once positioned, the balloon is inflated, expanding the stent to its desired size and pressing it against the vessel walls to restore proper blood flow. Typically made of materials such as stainless steel or cobalt-chromium, balloon-expandable stents are known for their high radial strength and precision in placement. They are widely used in coronary and peripheral artery diseases, offering an effective solution to treat blockages and reduce the risk of restenosis.

Balloon-Expandable Stents Market Dynamics

Drivers

• Increasing Prevalence of Cardiovascular Diseases

The rising incidence of coronary artery diseases (CAD), largely driven by lifestyle factors such as poor diet, lack of physical activity, and smoking, is a significant market driver for balloon-expandable stents. These risk factors contribute to the buildup of plaque in the arteries, leading to blockages that restrict blood flow. As CAD cases increase globally, the demand for effective treatments such as balloon-expandable stents rises. These stents help restore normal blood flow by expanding narrowed arteries, improving patient outcomes. With more individuals suffering from lifestyle-related heart conditions, the need for balloon-expandable stents is expected to grow, further propelling market expansion.

• Rising Awareness and Early Diagnosis

Greater awareness of cardiovascular risks and early diagnosis through advanced imaging technologies have become important drivers for the increasing use of balloon-expandable stents. With improved education on the risks associated with heart disease, individuals are more proactive in seeking medical care, leading to earlier detection of conditions such as coronary artery disease. Advanced imaging techniques, such as angiography and intravascular ultrasound, allow for precise identification of blockages and narrowing in arteries. This early detection enables timely interventions with balloon-expandable stents, improving patient outcomes. As awareness and diagnostic capabilities continue to grow, the demand for these stents is expected to rise, boosting market growth.

Opportunities

• Minimally Invasive Surgery Demand

With the increasing preference for minimally invasive procedures, balloon-expandable stents have become the treatment of choice for coronary artery disease. These stents offer several advantages, including precise placement, effective blood flow restoration, and reduced recovery times compared to traditional surgical methods. As patients and healthcare providers increasingly seek less invasive treatment options, the demand for balloon-expandable stents continues to rise. The ability of these stents to minimize hospital stays, decrease complications, and improve overall patient outcomes presents a significant market opportunity. This trend toward minimally invasive solutions is expected to drive the continued growth of the balloon-expandable stents market.

• Technological Advancements in Stent Materials

Innovations in stent materials, such as drug-eluting balloon-expandable stents and bioresorbable stents, present a significant growth opportunity in the market by offering improved patient outcomes. Drug-eluting stents release medication to prevent restenosis, reducing the such as lihood of artery re-blockage, while bioresorbable stents dissolve naturally over time, eliminating the need for permanent implants. These advancements minimize the risk of complications and improve the long-term effectiveness of treatments. As healthcare providers seek more efficient and patient-friendly options, the demand for these advanced stent designs is expected to grow, driving the market toward continued innovation and expansion.

Restraints/Challenges

• Complications and Side Effects

Although balloon-expandable stents are considered minimally invasive, they are not without potential complications, which can pose a significant challenge to their widespread adoption. Issues such as blood clots, infections, and stent migration can occur after the procedure, leading to compromised patient safety and reduced treatment efficacy. Blood clots can obstruct blood flow and cause further health issues, while infections at the stent site may require additional treatment. Stent migration can lead to misplacement, reducing its effectiveness. These complications may necessitate follow-up procedures, increasing healthcare costs and potentially affecting patient outcomes, thus representing a critical challenge in the balloon-expandable stents market.

•  High Treatment Cost

Advanced stents, such as drug-eluting and bioresorbable stents, offer significant benefits in treating coronary artery disease but come with high costs. The expensive nature of these stents can limit access for many patients, particularly in developing regions where healthcare infrastructure may be less developed or in countries with limited insurance coverage. For patients without adequate health insurance, the cost may be prohibitive, leading to delayed or avoided treatments. This economic barrier can restrict the adoption of advanced stents and hinder market growth, as a substantial portion of the population may not be able to afford these high-priced options.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Balloon-Expandable Stents Market Scope

The market is segmented on the basis of product type, product material, and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Bare-Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

Product Material

• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Others

End Users

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Balloon-Expandable Stents Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, product type, product material, and end users as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific dominates balloon-expandable stents market, due to the high prevalence of cardiovascular diseases and a growing aging population. The affordability of therapeutic tools and rapid technological advancements in the region further contribute to market growth. In addition, the increasing healthcare access and demand for advanced treatments in this area continue to drive the expansion of the market.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Balloon-Expandable Stents Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Balloon-Expandable Stents Market Leaders Operating in the Market Are:

• Medtronic (Ireland)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• BIOTRONIK, Inc. (Germany)
• B. Braun SE (Germany)
• Terumo Corporation (Japan)
• MicroPort Scientific Corporation (China)
• Meril Life Sciences Pvt. Ltd (India)
• ASOMEDICA (France)
• Vascular Concept (India)
• BD (U.S.)
• W. L. Gore & Associates, Inc. (U.S.)
• Endologix LLC (U.S.)
• Lombard Medical (U.K.)
• Translumina (Germany)
• JOTEC GmbH (Germany)
• Xcell Medical Group (India)

Latest Developments in Balloon-Expandable Stents Market

• In January 2024, W.L. Gore & Associates announced that it had received FDA approval for its lower-profile Viabahn VBX balloon-expandable endoprosthesis. This approval marks a significant advancement in the company's product offerings for vascular interventions. The new device is designed to provide enhanced performance in treating peripheral artery diseases with a more streamlined profile for easier deployment

SKU-54387